Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis
Blood Advances
· Elsevier
Аннотация
Publication date: 24 November 2026 Source: Blood Advances, Volume 10, Issue 22 Author(s): Douglas Tremblay, Amica Ko, Pavlina Chrysafi, Joan How, Rebecca Zon, Damon Houghton, Atefeh Ghorbanzadeh, Dahniel Sastow, Sai Swetha Alladi, Maria Georgen, Abi Prabhu, Vrushali Pachpande, Sai Sudha Valisekka, Balkrishna Jahagirdar, Sargam Kapoor, Andrew Peseski, Radhika Gangaraju, Ruchi Desai, Guoliang Zheng, Shreyash Dalmia
Читать у издателя →
Цитирование
Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S247395292600594X?dgcid=rss_sd_all
Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis. Blood Advances. https://www.sciencedirect.com/science/article/pii/S247395292600594X?dgcid=rss_sd_all
“Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis.” Blood Advances.
@article{article38137,
title = {Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S247395292600594X?dgcid=rss_sd_all}
}